Clinical Trial Update: Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT) [Phase 2]

View source ↗

Summary

Phase 2 trial update for StAR-VT, a stereotactic arrhythmia radiotherapy approach to treat ventricular tachycardia, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmic Storm
• Cardiac Arrhythmia
• Ventricular Tachycardia

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Ventricular Tachycardia, Arrhythmia | Phase 2 | Status: ENROLLING_BY_INVITATION